News und Analysen
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
Most smaller biotech companies would love to follow in the footsteps of Vertex Pharmaceuticals (NASDAQ: VRTX). The company is the global leader in cystic fibrosis (CF) treatments. And these products
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
Most smaller biotech companies would love to follow in the footsteps of Vertex Pharmaceuticals (NASDAQ: VRTX). The company is the global leader in cystic fibrosis (CF) treatments. And these products
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
Most smaller biotech companies would love to follow in the footsteps of Vertex Pharmaceuticals (NASDAQ: VRTX). The company is the global leader in cystic fibrosis (CF) treatments. And these products
EQS-News: Gerresheimer AG: Annual General Meeting backs growth course
2 Unstoppable Stocks to Buy Before the Bull Market
The market has been showing signs of life this year, but the S&P 500 remains down 10% since peaking in 2022. In a full-blown bull market, many businesses could see their valuations skyrocket
2 Unstoppable Stocks to Buy Before the Bull Market
The market has been showing signs of life this year, but the S&P 500 remains down 10% since peaking in 2022. In a full-blown bull market, many businesses could see their valuations skyrocket
2 Dividend Growth Stocks That Just Raised Their Payouts Again
Dividend stocks can make for great investments as they can be excellent sources of recurring income for your portfolio. And with dividend growth stocks, there's also a strong possibility that the
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: STRATEC SE: STRATEC FURTHER EXPANDS ITS PRESENCE IN USA BY ACQUIRING NATECH PLASTICS
Drug Maker Merck Sues US Gov. Over Inflation Reduction Act
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.
The war on drug
Why NovoCure Stock Is Crashing Today
Shares of NovoCure (NASDAQ: NVCR) were crashing 29.6% lower as of 10:19 a.m. ET on Tuesday. The steep decline came after the company announced data for its Tumor Treating Fields (TTFields) therapy
Why Shares of HealthEquity Are Up Tuesday
Shares of HealthEquity (NASDAQ: HQY) were up more than 13% Tuesday morning after the healthcare services company reported earnings after the markets closed on Monday. The stock is up more than 9% so
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Wall Street Says These 2 Stocks May Double. Should You Buy Them?
One of the exciting parts of investing is identifying companies that will offer us the next big thing. This could be a game-changing drug or an exciting technology that may transform healthcare. And
Why Shares of Amedisys Are Jumping Monday
Shares of home healthcare solutions company Amedisys (NASDAQ: AMED) were up more than 14% Monday morning after the company reported that it had received an unsolicited buyout offer from Optum, a
EQS-AGM: Fresenius Medical Care AG & Co. KGaA: Announcement of the Convening of the General Meeting in Frankfurt am Main on 14.07.2023 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
2 Dividend Kings Down 12% and 14% You'll Regret Not Buying on The Dip
Dividend Kings are among the most steady corporations on the market. While many businesses don't even last a decade, these companies have survived and thrived and raised their payouts for at least
This Biotech Could Soon Go Parabolic, But Should You Buy It?
In the often-volatile world of biotech stocks, shares of small-cap Blueprint Medicines (NASDAQ: BPMC) have proven surprisingly steady over the past 12 months. But the stock could be gearing up for a
Wall Street Says This Growth Stock Is a Buy, but Is It Overvalued?
A struggling economy and a bear market haven't been able to stop Vertex Pharmaceuticals (NASDAQ: VRTX). Over the past year, the company's shares are up by 17%. And Wall Street continues to be
Wall Street Says This Growth Stock Is a Buy, but Is It Overvalued?
A struggling economy and a bear market haven't been able to stop Vertex Pharmaceuticals (NASDAQ: VRTX). Over the past year, the company's shares are up by 17%. And Wall Street continues to be
Wall Street Says This Growth Stock Is a Buy, but Is It Overvalued?
A struggling economy and a bear market haven't been able to stop Vertex Pharmaceuticals (NASDAQ: VRTX). Over the past year, the company's shares are up by 17%. And Wall Street continues to be
Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade
People saving for retirement often dream of crossing the $1 million milestone. While it is far from obvious that this amount is enough to live out the rest of one's life comfortably, it is still a